Oral semaglutide disappoints in the two evoke trials, failing to reduce the rate of cognitive decline #Alzheimers disease #Dementia www.novonordisk.com/content/nnco...
24.11.2025 11:31 β π 3 π 2 π¬ 0 π 0@danieljdrucker.bsky.social
A clinician scientist at LTRI @sinaihealth studying Glucagon, GIP, GLP-1, GLP-2, diabetes, obesity, metabolism and the gut endocrine system
Oral semaglutide disappoints in the two evoke trials, failing to reduce the rate of cognitive decline #Alzheimers disease #Dementia www.novonordisk.com/content/nnco...
24.11.2025 11:31 β π 3 π 2 π¬ 0 π 0On the cusp of closing the genetic association and mechanism gap while laying the foundation for future precision medicine approaches in type 2 #diabetes #genetics @diabetologiajnl.bsky.social link.springer.com/article/10.1...
22.11.2025 20:54 β π 9 π 3 π¬ 0 π 1P3 data for Efsubaglutide the once weekly immunoglobulin-based GLP-1 medicine approved in China for #T2D @diabetologiajnl.bsky.social link.springer.com/article/10.1...
22.11.2025 20:15 β π 6 π 1 π¬ 0 π 0A reminder of the primary endpoint in the evoke trials, the change in the CDR β Sum of Boxes (CDR-SB) score from baseline to week 104 #Alzheimers www.understandingalzheimersdisease.com/-/media/File...
22.11.2025 11:58 β π 0 π 0 π¬ 0 π 0As disclosure of evoke and evoke+ trial results for oral semaglutide in people with imaging or biomarker+ #Alzheimers disease approaches, a reminder of the primary and secondary endpoints alzres.biomedcentral.com/articles/10....
22.11.2025 11:46 β π 5 π 1 π¬ 1 π 0Human #genetic evidence in humans is consistent with direct TAS2R38 actions in postprandial glycemia, supporting TAS2R38 as a novel therapeutic target for glucose regulation.
diabetesjournals.org/diabetes/art...
Towards reducing the already low risk of peri-procedural GLP-1 medicines linked aspiration. Fasting duration, rather than time since last GLP-1 dose, is a key determinant of retained gastric solid content link.springer.com/article/10.1...
21.11.2025 11:22 β π 2 π 0 π¬ 0 π 0Studies in aging male mice with extensive multi-OMICs analyses show that glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment broadly counteracts age-related changes n part via the hypothalamic GLP-1R #aging www.cell.com/cell-metabol...
21.11.2025 01:36 β π 6 π 2 π¬ 1 π 0Preclinical studies reveal that CCKBR-Gs and -Gq signaling, rather than CCKBR-Gi signaling, are beneficial for #Alzheimers disease (AD) treatment. www.cell.com/cell/abstrac...
21.11.2025 01:26 β π 3 π 0 π¬ 0 π 0A small P2 trial of 24 patients with #T1D randomized to placebo vs. Tirzepatide. Meaningful #weightloss without SAEs
diabetesjournals.org/care/article... ada.silverchair-cdn.com/ada/content_...
A spotlight on key concepts defining postprandial glucagon metabolism in people with and without type 1 #diabetes diabetesjournals.org/diabetes/art...
20.11.2025 21:46 β π 4 π 1 π¬ 0 π 0Preclinical data suggest that GLY-200, an orally administered polymer that targets mucus and enhances barrier function, in combination with GLP-1RAs, holds promise as a
novel therapeutic strategy for #obesity www.sciencedirect.com/science/arti...
Can one target SLC25A51 the major determinant of the mitochondrial NAD+ pool to improve hepatocyte health and regeneration? www.nature.com/articles/s42...
20.11.2025 12:07 β π 6 π 1 π¬ 0 π 0Here using #genetics proxies and association with measurable GLP-1R dependent variables, the authors dismiss the non-metabolic roles of GLP1R in relevant cardiovascular tissues for GLP-1R dependent cardioprotection diabetesjournals.org/care/article... ada.silverchair-cdn.com/ada/content_...
19.11.2025 22:11 β π 4 π 0 π¬ 0 π 0Does the future of managing benign thyroid dysfunction encompass incorporation of #genetics in personalized management of thyroid diseases? academic.oup.com/jcem/advance...
19.11.2025 20:42 β π 3 π 0 π¬ 0 π 0The ongoing allure of intestinally-restricted TGR5 ligands for increasing GLP-1 and the treatment of metabolic disorders #diabetes #obesity here with a non-absorbable carrier drug conjugate www.science.org/doi/10.1126/...
19.11.2025 19:55 β π 3 π 0 π¬ 0 π 0The 100 yr pursuit for non-injectable #insulin ..Here based on mouse and mini pig data, βa skin-permeable polymer may enable non-invasive transdermal delivery of insulin, relieving patients with #diabetes from subcutaneous injectionsβ www.nature.com/articles/s41...
19.11.2025 17:20 β π 7 π 3 π¬ 1 π 0In Finland #Prediabetes was prevalent in pediatric patients with #obesity and was associated particularly with steatotic liver disease and prevalence increased steeply over time, independent of the degree of obesity www.nature.com/articles/s41...
19.11.2025 11:43 β π 2 π 0 π¬ 0 π 0The consequences of misinformation are real and often tragic #vaccines #measles www.nature.com/articles/d41...
19.11.2025 11:32 β π 5 π 4 π¬ 1 π 0#ENDO2026 Abstract Submissions Are Now Open | Share your research to earn media coverage for your work. Accepted abstracts may be published in a supplement to our Open Access publication, #JES. The deadline is Thursday, January 15: https://bit.ly/49lxDqp #EndoSky @endosocjournals.bsky.social
18.11.2025 23:00 β π 0 π 1 π¬ 0 π 0An update on the Neural Regulation of Blood Glucose in Acute Stress from Professor Stanley @AmDiabetesAssn diabetesjournals.org/diabetes/art...
18.11.2025 22:45 β π 5 π 1 π¬ 0 π 0New insights into islet ER stress responses, proinsulin biosynthesis, ERAD and ERD1 using Ξ²-cell-specific Hrd1-KO mice & rodent (and human islet) Ξ²-cells treated acutely with HRD1 inhibitor. jci.org/articles/vie...
@jci.org
In adults with a history of seizure disorder in TriNetX, GLP-1 RA initiation was associated with reduced risks of seizure recurrence, hospitalization, and mortality compared with other glucose-lowering therapies onlinelibrary.wiley.com/doi/10.1111/...
18.11.2025 15:53 β π 4 π 1 π¬ 0 π 0Canadaβs research and scientific spending is declining relative to other nations, Council of Canadian Academies report says, by @ivansemeniuk.bsky.social www.theglobeandmail.com/canada/scien... via @theglobeandmail.com
18.11.2025 15:47 β π 21 π 11 π¬ 1 π 2Does genetic variation in GLP-2R signaling influence the development of binge eating disorders and/or the therapeutic response to GLP-1 medicines? #Bulimia www.sciencedirect.com/science/arti...
18.11.2025 11:22 β π 5 π 1 π¬ 0 π 0Here the authors reveal precise preventive and therapeutic strategies to ameliorate Insulin Resistance-related cardiometabolic health and longevity www.nature.com/articles/s41...
18.11.2025 01:18 β π 5 π 0 π¬ 0 π 0How does tirzepatide talk to your brain and quiet food noise? A case report with electrophysiological insights www.nature.com/articles/s41...
17.11.2025 20:01 β π 5 π 1 π¬ 0 π 0Revisiting the traditional paradigms and goals for initial management of #T2D A focus on achievement of #weightloss with cost effective GLP-1 medicines diabetesjournals.org/care/article... ada.silverchair-cdn.com/ada/content_...
17.11.2025 11:49 β π 4 π 0 π¬ 0 π 0An optogenetics enabled enteric nervous system epithelium gut organ platform for systematic discovery and mechanistic exploration of functional neuroimmune connections www.nature.com/articles/s41...
17.11.2025 11:43 β π 3 π 1 π¬ 0 π 0Preclinical studies highlight the biological rationale for targeting NLRP3 w/wo GLP-1R agonism in inflammatory conditions such as #obesity www.sciencedirect.com/science/arti...
16.11.2025 13:11 β π 4 π 1 π¬ 0 π 0